Apr 1, 2026 · Denosumab is a human monoclonal antibody that works by inhibiting RANKL (receptor activator of nuclear factor kappa-B ligand), a protein essential for osteoclasts' formation, function, …

Mar 1, 2026 · Denosumab injection is used to treat osteoporosis (thinning of the bones) in women who have an increased risk for fractures after menopause, and osteoporosis in men. It is given when …

Denosumab inhibits this maturation of osteoclasts by binding to and inhibiting RANKL. Denosumab mimics the natural action of osteoprotegerin, an endogenous RANKL inhibitor, that presents with …

Prolia® injection is a brand of denosumab, which treats osteoporosis. Osteoporosis is a condition that weakens your bones, making them more susceptible to fractures.

Bone, joint, or muscle pain. Some people who take Prolia® develop severe bone, joint, or muscle pain. Do not take Prolia® if you: have low blood calcium; or are pregnant or plan to become pregnant, as …

Jul 3, 2024 · What is denosumab used for? Denosumab (Prolia, Jubbonti, Stoboclo) is commonly used to treat osteoporosis, a condition in which the bones are thinner, weaker, and more prone to …

Denosumab injection is in a class of medications called RANK ligand inhibitors. It works to prevent bone loss by blocking a certain receptor in the body to decrease bone breakdown.

Denosumab (Prolia) is a biologic medication used to prevent fragile bones, also known as osteoporosis, and bone fractures. See how to take it and side effects.

Denosumab is a human IgG2 monoclonal antibody used to treat bone problems that may occur with cancer that has spread (metastasized) to the bones. Learn about side effects, dosages, drug …

Denosumab is a lab-made human monoclonal immunoglobulin G2 (IgG2) antibody medication used to reduce bone loss in patients at high risk for bone fractures due to postmenopausal osteoporosis, …